NCT00002174View on ClinicalTrials.gov

Further Evaluation of Thalidomide's Ability to Potentiate the Immune Response to HIV-Infected Patients

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

Not specified

Conditions

HIV Infections

Interventions

DRUG

Thalidomide

Trial Locations (1)

70102

Ochsner Clinic, New Orleans

All Listed Sponsors

lead

Louisiana State University Health Sciences Center in New Orleans

OTHER

NCT00002174 - Further Evaluation of Thalidomide's Ability to Potentiate the Immune Response to HIV-Infected Patients | Biotech Hunter | Biotech Hunter